Challenges and opportunities for the development of new antipsychotic drugs
- 1 November 2017
- journal article
- review article
- Published by Elsevier BV in Biochemical Pharmacology
- Vol. 143, 10-24
- https://doi.org/10.1016/j.bcp.2017.05.009
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Glutamate Levels in the Associative Striatum Before and After 4 Weeks of Antipsychotic Treatment in First-Episode PsychosisJAMA Psychiatry, 2013
- Dopamine system dysregulation by the hippocampus: Implications for the pathophysiology and treatment of schizophreniaNeuropharmacology, 2012
- High Frequencies of De Novo CNVs in Bipolar Disorder and SchizophreniaNeuron, 2011
- Intermediate phenotypes in psychiatric disordersCurrent Opinion in Genetics & Development, 2011
- The Human Brain in a Dish: The Promise of iPSC-Derived NeuronsCell, 2011
- Insights into the neurodevelopmental origin of schizophrenia from postmortem studies of prefrontal cortical circuitryInternational Journal of Developmental Neuroscience, 2011
- The chandelier neuron in schizophreniaDevelopmental Neurobiology, 2010
- Neuropsychology of the Prodrome to Psychosis in the NAPLS ConsortiumRelationship to Family History and Conversion to PsychosisNeuropsychology of Prodrome to PsychosisArchives of General Psychiatry, 2010
- Differential Targeting of the CA1 Subfield of the Hippocampal Formation by Schizophrenia and Related Psychotic DisordersArchives of General Psychiatry, 2009
- A scientific agenda for the concept of recovery as it applies to schizophreniaClinical Psychology Review, 2008